HDAC2 and triple-negative breast carcinoma: The 40 triple negative breast cancer tissue specimens showed a higher percentage of HDAC-2 overexpression, compared to the 98 non-triple negative breast cancer tissues that met the study criteria (27.5% vs. 12.2%, p = 0.029) (Table 3 and Figure 3).